Oasmia Pharmaceutical AB Analysis
Oasmia Pharmaceutical AB is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Oasmia Pharmaceutical pink sheet analysis is to determine its intrinsic value, which is an estimate of what Oasmia Pharmaceutical AB is worth, separate from its market price. There are two main types of Oasmia Pharmaceutical's stock analysis: fundamental analysis and technical analysis.
The Oasmia Pharmaceutical pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Oasmia |
Oasmia Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.68. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oasmia Pharmaceutical last dividend was issued on the 25th of March 2022. The entity had 1673:1223 split on the 15th of November 2019. Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology primarily in Sweden. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden. Vivesto Ab operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 17 people.The quote for Oasmia Pharmaceutical AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Oasmia Pharmaceutical AB contact the company at 46 18 50 54 40 or learn more at https://www.vivesto.com.Oasmia Pharmaceutical Investment Alerts
| Oasmia Pharmaceutical is not yet fully synchronised with the market data | |
| Oasmia Pharmaceutical has some characteristics of a very speculative penny stock | |
| Oasmia Pharmaceutical has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M). | |
| Oasmia Pharmaceutical generates negative cash flow from operations |
Oasmia Pharmaceutical Thematic Classifications
In addition to having Oasmia Pharmaceutical pink sheet in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Oasmia Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 21.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oasmia Pharmaceutical's market, we take the total number of its shares issued and multiply it by Oasmia Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Oasmia Pharmaceutical Outstanding Bonds
Oasmia Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Oasmia Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Oasmia bonds can be classified according to their maturity, which is the date when Oasmia Pharmaceutical AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| US674215AL24 Corp BondUS674215AL24 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Oasmia Pharmaceutical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Oasmia Pink Sheet
If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |